← Back to Search

Electrophysiological Study for Atrioventricular Nodal Reentry Tachycardia (AVNRT Trial)

N/A

Waitlist Available

Led By Deborah Lockwood, M.D.

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages 16-80

Patient scheduled for electrophysiology study and catheter ablation for supraventricular tachycardia

Timeline

Screening 3 weeks

Treatment Varies

Follow Up unk

Awards & highlights

AVNRT Trial Summary

This trial is testing what causes a heart condition called AV nodal reentrant tachycardia.

Who is the study for?

This trial is for people aged 16-80 who have had at least one documented episode of a rapid heartbeat condition called AV nodal reentrant tachycardia and are scheduled for a special heart study and treatment. It's not for those under 16 or over 80, pregnant individuals, patients with conditions that could prolong the procedure or increase X-ray exposure, those who've had prior treatments with long radiation exposure, or if they can't come back for follow-up.Check my eligibility

What is being tested?

The study aims to understand the factors involved in AV nodal reentrant tachycardia by using an invasive cardiac procedure known as an electrophysiological study. Participants will undergo this specialized heart test to identify what triggers their rapid heartbeat.See study design

What are the potential side effects?

While specific side effects aren't listed here, invasive cardiac procedures like electrophysiological studies may include risks such as bleeding at the catheter site, infection, damage to blood vessels or heart tissue, irregular heartbeats, and rarely more serious complications.

AVNRT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 16 and 80 years old.

Select...

I am scheduled for a procedure to treat my rapid heartbeat.

AVNRT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ unk

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~unk

This trial's timeline: 3 weeks for screening, Varies for treatment, and unk for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

raise the frequency of success to more than 98%

AVNRT Trial Design

1Treatment groups

Experimental Treatment

Group I: Study ArmExperimental Treatment1 Intervention

Mapping and Ablation

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor

455 Previous Clinical Trials

97,510 Total Patients Enrolled

Deborah Lockwood, M.D.Principal InvestigatorUniversity of Oklahoma

Media Library

Cardiac Invasive Electrophysiological Study Clinical Trial Eligibility Overview. Trial Name: NCT00618683 — N/A

Atrioventricular Nodal Reentry Tachycardia Research Study Groups: Study Arm

Atrioventricular Nodal Reentry Tachycardia Clinical Trial 2023: Cardiac Invasive Electrophysiological Study Highlights & Side Effects. Trial Name: NCT00618683 — N/A

Cardiac Invasive Electrophysiological Study 2023 Treatment Timeline for Medical Study. Trial Name: NCT00618683 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria should be met to make someone eligible for this research?

"This clinical trial will include 100 people aged 16-80 who have experienced at least one instance of AV nodal reentrant tachycardia. To qualify, applicants must satisfy the requisite conditions: having had said episode and falling within the aforementioned age bracket."

Answered by AI

Is it currently possible for participants to join this investigation?

"As of the April 21st 2020 update, clinicaltrials.gov does not list this trial as an active recruitment study. Initially posted on March 1 2004, there are currently 122 ongoing trials which actively require participants to join their studies."

Answered by AI

Does this clinical experiment have an age limit and, if so, is it above 30 years?

"This medical trial requires its participants to be between the age of 16 and 80. For younger patients, there are 14 appropriate trials while 97 studies exist for seniors beyond 65 years old."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

AV Nodal Reentrant Tachycardia Study

2004. "AV Nodal Reentrant Tachycardia Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00618683.